IL100021A0 - Non-aqueous microemulsions for drug delivery - Google Patents

Non-aqueous microemulsions for drug delivery

Info

Publication number
IL100021A0
IL100021A0 IL100021A IL10002191A IL100021A0 IL 100021 A0 IL100021 A0 IL 100021A0 IL 100021 A IL100021 A IL 100021A IL 10002191 A IL10002191 A IL 10002191A IL 100021 A0 IL100021 A0 IL 100021A0
Authority
IL
Israel
Prior art keywords
drug delivery
aqueous microemulsions
microemulsions
aqueous
drug
Prior art date
Application number
IL100021A
Other languages
English (en)
Original Assignee
Affinity Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Affinity Biotech Inc filed Critical Affinity Biotech Inc
Publication of IL100021A0 publication Critical patent/IL100021A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL100021A 1990-11-13 1991-11-11 Non-aqueous microemulsions for drug delivery IL100021A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/612,592 US5110606A (en) 1990-11-13 1990-11-13 Non-aqueous microemulsions for drug delivery

Publications (1)

Publication Number Publication Date
IL100021A0 true IL100021A0 (en) 1992-08-18

Family

ID=24453815

Family Applications (1)

Application Number Title Priority Date Filing Date
IL100021A IL100021A0 (en) 1990-11-13 1991-11-11 Non-aqueous microemulsions for drug delivery

Country Status (7)

Country Link
US (1) US5110606A (ja)
EP (1) EP0561874A1 (ja)
JP (1) JPH05509332A (ja)
AU (1) AU648483B2 (ja)
CA (1) CA2095819A1 (ja)
IL (1) IL100021A0 (ja)
WO (1) WO1992008445A1 (ja)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU668679B2 (en) * 1991-02-18 1996-05-16 Transdermal Technologies Pty Limited Composition for use in transdermal administration
AU668509B2 (en) * 1991-04-19 1996-05-09 Affinity Biotech, Inc. Convertible microemulsion formulations
US5688761A (en) * 1991-04-19 1997-11-18 Lds Technologies, Inc. Convertible microemulsion formulations
GB9207988D0 (en) * 1992-04-10 1992-05-27 Smithkline Beecham Plc Topical composition
EP0666752A4 (en) * 1992-10-16 1996-09-11 Smithkline Beecham Corp THERAPEUTIC MICROEMULSIONS.
EP0684834A4 (en) * 1993-02-17 1996-09-25 Smithkline Beecham Corp MICROEMULSIONS CONTAINING THERAPEUTIC PEPTIDES.
EP0684833A4 (en) * 1993-02-17 1996-09-11 Smithkline Beecham Corp MICRO-EMULSIONS COMPRISING THERAPEUTIC PEPTIDES.
NZ262679A (en) * 1993-02-22 1997-08-22 Vivorx Pharmaceuticals Inc Compositions for in vivo delivery of pharmaceutical agents where the agents are contained in a polymeric shell
US5439686A (en) * 1993-02-22 1995-08-08 Vivorx Pharmaceuticals, Inc. Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
US5997904A (en) * 1993-02-22 1999-12-07 American Bioscience, Inc. Total nutrient admixtures as stable multicomponent liquids or dry powders and methods for the preparation thereof
US5916596A (en) * 1993-02-22 1999-06-29 Vivorx Pharmaceuticals, Inc. Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
US20030133955A1 (en) * 1993-02-22 2003-07-17 American Bioscience, Inc. Methods and compositions useful for administration of chemotherapeutic agents
US5665382A (en) * 1993-02-22 1997-09-09 Vivorx Pharmaceuticals, Inc. Methods for the preparation of pharmaceutically active agents for in vivo delivery
US20030068362A1 (en) * 1993-02-22 2003-04-10 American Bioscience, Inc. Methods and formulations for the delivery of pharmacologically active agents
US6528067B1 (en) 1993-02-22 2003-03-04 American Bioscience, Inc. Total nutrient admixtures as stable multicomponent liquids or dry powders and methods for the preparation thereof
US6753006B1 (en) 1993-02-22 2004-06-22 American Bioscience, Inc. Paclitaxel-containing formulations
US5650156A (en) * 1993-02-22 1997-07-22 Vivorx Pharmaceuticals, Inc. Methods for in vivo delivery of nutriceuticals and compositions useful therefor
WO1995005176A1 (en) * 1993-08-18 1995-02-23 Alcon Laboratories, Inc. Use of ergoline derivatives for the treatment of glaucoma
US5430021A (en) * 1994-03-18 1995-07-04 Pharmavene, Inc. Hydrophobic drug delivery systems
WO1995031979A1 (en) * 1994-05-19 1995-11-30 R.P. Scherer International Corporation Solutions of aryl or heteroaryl substituted alkanoic acids in lipophilic solvents and soft gelatin capsules containing such solutions
US5484800A (en) * 1994-08-30 1996-01-16 American Home Products Corporation Lipid-based liquid medicinal composition
US5576344A (en) * 1994-08-30 1996-11-19 American Home Products Corporation Process for reducing the adverse taste and malodor associated with H2 -antagonists
US5560931A (en) * 1995-02-14 1996-10-01 Nawosystems L.L.C. Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids
US6245349B1 (en) * 1996-02-23 2001-06-12 éLAN CORPORATION PLC Drug delivery compositions suitable for intravenous injection
GB9625589D0 (en) * 1996-12-10 1997-01-29 Boots Co Plc Therapeutic agents
US20030216303A1 (en) * 1998-03-06 2003-11-20 Michael Ambuhl Emulsion preconcentrates containing cyclosporin or a macrolide
US6638522B1 (en) * 1998-12-11 2003-10-28 Pharmasolutions, Inc. Microemulsion concentrate composition of cyclosporin
US20040258763A1 (en) * 1999-02-03 2004-12-23 Bell Steve J.D. Methods of manufacture and use of calcium phosphate particles containing allergens
WO2000046147A2 (en) * 1999-02-03 2000-08-10 Biosante Pharmaceuticals, Inc. Therapeutic calcium phosphate particles and methods of manufacture and use
US20020054914A1 (en) * 1999-02-03 2002-05-09 Tulin Morcol Compositions and methods for therapuetic agents complexed with calcium phosphate and encased by casein
US7658938B2 (en) 1999-02-22 2010-02-09 Merrion Reasearch III Limited Solid oral dosage form containing an enhancer
US20070148228A1 (en) * 1999-02-22 2007-06-28 Merrion Research I Limited Solid oral dosage form containing an enhancer
US8119159B2 (en) * 1999-02-22 2012-02-21 Merrion Research Iii Limited Solid oral dosage form containing an enhancer
US6794411B1 (en) 1999-04-06 2004-09-21 Laboratoire Des Produits Ethiques Ethypharm Drinkable ibuprofen pharmaceutical suspension
GB9912476D0 (en) * 1999-05-28 1999-07-28 Novartis Ag Organic compounds
US20060062855A1 (en) * 2001-02-27 2006-03-23 Bell Steve J D Therapeutic calcium phosphate particles for use in inhibiting expression of a gene
US20030185892A1 (en) * 2001-08-17 2003-10-02 Bell Steve J. D. Intraocular delivery compositions and methods
US20030054042A1 (en) * 2001-09-14 2003-03-20 Elaine Liversidge Stabilization of chemical compounds using nanoparticulate formulations
ES2201894B2 (es) * 2002-01-18 2005-03-01 Industrial Management, S.A Procedimiento para producir combustibles biodiesel con propiedades mejoradas a baja temperatura.
US20080220075A1 (en) * 2002-03-20 2008-09-11 Elan Pharma International Ltd. Nanoparticulate compositions of angiogenesis inhibitors
WO2003080027A1 (en) * 2002-03-20 2003-10-02 Elan Pharma International, Ltd. Nanoparticulate compositions of angiogenesis inhibitors
US20060194699A1 (en) * 2003-01-10 2006-08-31 Moucharafieh Nadim C Sprayable non-aqueous, oil-continuous microemulsions and methods of making same
ITMI20032019A1 (it) * 2003-10-17 2005-04-18 Fidia Farmaceutici Microemulsioni di retinoidi e composizioni farmaceutiche che le contengono
CA2586035A1 (en) * 2004-11-01 2006-05-11 Biosante Pharmaceuticals, Inc. Therapeutic calcium phosphate particles in use for aesthetic or cosmetic medicine, and methods of manufacture and use
BRPI0710503A2 (pt) * 2006-04-07 2011-08-16 Merrion Res Iii Ltd uso de uma composição farmacêutica, composição farmacêutica, e, forma de dosagem oral
US8445545B2 (en) * 2008-05-07 2013-05-21 Nicholas DeSica Pharmaceutical composition, method of preparation and methods of treating aches/pains
RU2517135C2 (ru) * 2008-05-07 2014-05-27 Меррион Рисерч Iii Лимитед Композиции пептидов и способы их получения
CA2751854A1 (en) * 2009-02-25 2010-09-02 Merrion Research Iii Limited Composition and drug delivery of bisphosphonates
US20110182985A1 (en) * 2010-01-28 2011-07-28 Coughlan David C Solid Pharmaceutical Composition with Enhancers and Methods of Preparing thereof
US20110200645A1 (en) * 2010-02-18 2011-08-18 Martek Biosciences Corporation DHA Free Fatty Acid Emulsions
US9089484B2 (en) * 2010-03-26 2015-07-28 Merrion Research Iii Limited Pharmaceutical compositions of selective factor Xa inhibitors for oral administration
KR20140026354A (ko) 2011-01-07 2014-03-05 메리온 리서치 Ⅲ 리미티드 경구 투여용 철의 제약 조성물
JP2014517046A (ja) * 2011-06-24 2014-07-17 アセンダ ファーマ インコーポレイテッド エステルプロドラッグの吸収を改善するための方法及び改善された医薬組成物
EP2760433B1 (en) 2011-09-29 2023-05-31 PLx Opco Inc. pH DEPENDENT CARRIERS FOR TARGETED RELEASE OF PHARMACEUTICALS ALONG THE GASTROINTESTINAL TRACT, COMPOSITIONS THEREFROM, AND MAKING AND USING SAME
GB2533669B (en) 2014-12-23 2016-12-14 Innovate Pharmaceuticals Ltd Salicylate compound composition
JP7211704B2 (ja) 2015-01-29 2023-01-24 ノヴォ ノルディスク アー／エス Ｇｌｐ－１アゴニスト及び腸溶コーティングを含む錠剤
CN104800159A (zh) * 2015-04-08 2015-07-29 中山大学 一种布洛芬微乳给药系统
WO2016198469A1 (en) 2015-06-09 2016-12-15 Hpf Ip Holding S.A. Penetration of alpha-hydroxy acids from water-free emulsions
CN105617133B (zh) * 2016-02-17 2020-04-28 广州欧化药业有限公司 复合牡丹籽油自乳化体系组合物及其制备方法
JP2023518822A (ja) 2020-03-26 2023-05-08 ピーエルエックス オプコ インコーポレイテッド ｐＨ依存的再構築が可能な医薬キャリア、その製造方法及び使用方法
US20230364172A1 (en) * 2022-05-14 2023-11-16 Syncotrance, LLC Modulation of solubility, palatability, absorption, and bioavailability of mitragyna speciosa-derived compounds for oral and buccal delivery

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4051257A (en) * 1974-01-10 1977-09-27 Jelenko Iii Carl Topical veterinary dermatological medicament
DE3225703C1 (de) * 1982-07-09 1984-01-19 A. Nattermann & Cie GmbH, 5000 Köln Phospholipidkonzentrat und seine Verwendung als Hilfsstoff zum Herstellen und Austragen von Pflanzenschutzmittel enthaltenden Spritzbruehen
DE3225706C2 (de) * 1982-07-09 1984-04-26 A. Nattermann & Cie GmbH, 5000 Köln Flüssige Wirkstofformulierungen in Form von Konzentraten für Mikroemulsionen
DE3406497A1 (de) * 1984-02-23 1985-09-05 Mueller Bernhard Willi Werner Hochdisperse pharmazeutische mehrkomponentensysteme und verfahren zu ihrer herstellung
GB8630273D0 (en) * 1986-12-18 1987-01-28 Til Medical Ltd Pharmaceutical delivery systems
US4851444A (en) * 1987-07-10 1989-07-25 Analgesic Associates Onset-hastened/enhanced analgesia
US4874605A (en) * 1987-11-27 1989-10-17 Hoechst-Roussel Pharmaceuticals Inc. Stabilized delayed release emulsion
US4883660A (en) * 1988-10-17 1989-11-28 Thames Pharmacal Co., Inc. Gel bases for pharmaceutical compositions

Also Published As

Publication number Publication date
EP0561874A4 (en) 1993-07-29
JPH05509332A (ja) 1993-12-22
EP0561874A1 (en) 1993-09-29
US5110606A (en) 1992-05-05
WO1992008445A1 (en) 1992-05-29
CA2095819A1 (en) 1992-05-14
AU9054191A (en) 1992-06-11
AU648483B2 (en) 1994-04-21

Similar Documents

Publication Publication Date Title
IL100021A0 (en) Non-aqueous microemulsions for drug delivery
CS285491A3 (en) Nasal pharmaceutical
CS375691A3 (en) Pharmaceutical agents
AP9100283A0 (en) Pharmaceutical compounds
AU7115791A (en) Cryogen delivery apparatus
GB8909046D0 (en) Controlled delivery devices
GB9008123D0 (en) Pharmaceutical compounds
ZA911454B (en) Cryogen delivery apparatus
EP0600754A3 (en) Continuous flow pharmaceutical transfusion.
GB9008657D0 (en) Medication dispensing
GB2274273B (en) Medicament pack
GB9000241D0 (en) Pharmaceutical use
GB9013977D0 (en) Medicament container
GB9000627D0 (en) Medicament container
IL94455A0 (en) Drug dispenser
ZA917789B (en) Pharmaceutical preparation.
IE893139L (en) Controlled drug delivery
GB9022669D0 (en) Medicament
GB8924961D0 (en) Medicament container
GB8914222D0 (en) Medicament container
GB8919996D0 (en) Medicament container
GB8919995D0 (en) Medicament container
GB8919997D0 (en) Medicament container
GB8921462D0 (en) Medicament container
GB8924949D0 (en) Medicament container